Rigid gas permeable lens highly influences the interpretation of CXL results

Article

Wearing a rigid gas permeable lens can lead to improved topographic parameters and can significantly alter a number of study parameters.

Wearing a rigid gas permeable lens can lead to improved topographic parameters and can significantly alter a number of study parameters, claims a paper published in the British Journal of Ophthalmology.

A prospective, non-comparative study led by Dr Koppen Carina, Department of Ophthalmology, Antwerp University Hospital, Belgium, comprised of 15 eyes without rigid gas permeable contact lens (CL) and 12 eyes fitted with a CL from 1 to 10 weeks after ultraviolet A/riboflavin cross-linking (CXL) for the stabilisation of progressive keratoconus.

Refractive sphere and cylinder, maximal keratometry value (K max), simulated keratometry steep, flat, astigmatism, refractive power (RP) steep, flat and astigmatism, I-S value on EyeSys, K max on Pentacam and change from baseline of best spectacle-corrected visual acuity (BSCVA) were all used to measure the effect of CXL treatment on patients. The results of the study were recorded pre-CXL and in 6 month intervals for 18 months post-CXL.

There were no study parameters that demonstrated a significant change from baseline results in eyes without CL.

However, in eyes fitted with CL post-CXL I-S value and K max on EyeSys at all time intervals, RP steep and simulated astigmatism at 6 and 12 months and RP flat at 12 months all showed significant improvement.

CL can greatly influence the interpretation of CXL results, with lens wear improving topographic parameters.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.